RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Announce New $750 Million State-of-the-Art, Free-Standing Cancer Pavilion in New Brunswick
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, part of Rutgers Health, in partnership with New Brunswick Development Corporation announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. The initial estimated project cost is $750 million.
The new pavilion will house key outpatient services, including those for chemotherapy and radiation therapy, as well as the major diagnostic modalities, and inpatient cancer services.
The space will also feature research laboratories, enabling physician-scientists to more rapidly translate scientific findings from laboratory bench to patient bedside, resulting in clinical assessment, feedback on clinical trials and collection of research data in a more rapid and direct fashion. Research is a core pillar of Rutgers Cancer Institute, the state’s only National Cancer Institute-designated Comprehensive Cancer Center. As New Jersey’s largest and most comprehensive academic healthcare system, RWJBarnabas Health works in partnership with Rutgers Cancer Institute to provide the most advanced patient-centric, integrated cancer care close to home for residents throughout the state.
“The Cancer Pavilion will be a model for cancer care delivery on the East Coast, bringing together the three mission areas of academic medicine – research, education, and patient care – all under one roof,” said Barry H. Ostrowsky, President and Chief Executive Officer, RWJBarnabas Health.
The pavilion will be located on property immediately adjacent to the existing Robert Wood Johnson University Hospital and Rutgers Cancer Institute of New Jersey campus, although its exact location is still being identified.
"The Rutgers Cancer Institute of New Jersey and RWJBarnabas are already at the forefront of life-saving treatments for their patients because of their commitment to modern and evolving healthcare for all," said Mayor Jim Cahill. "The realization of this new facility will allow for even more services, treatment and hope for those who seek the aid of these globally-renowned institutions in an epicenter of cutting-edge medical and research technology and innovation that will help shape a better tomorrow."
“This new state-of-the-art free-standing cancer pavilion featuring inpatient capacity coupled with research laboratories is a first of its kind in our state. It is only fitting that it will encapsulate the wide-ranging oncology care services offered by Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with RWJBarnabas Health, New Jersey’s largest health system,” notes Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also the senior vice president of oncology services at RWJBarnabas Health. “By providing inpatient care in conjunction with world-class treatment and unique patient amenities all in one footprint, we are enhancing the level of care for the patients we serve in New Jersey and beyond.”
“Together, RWJBarnabas Health and the Rutgers Cancer Institute of New Jersey are committed to providing New Jersey cancer patients with the most advanced treatments available and the development of the new cancer pavilion in New Brunswick will ensure that those vital resources are easily accessible right here in our state,” said Brian L. Strom, MD, MPH, Chancellor, Rutgers Biomedical and Health Sciences, Executive Vice President, Health Affairs, Rutgers University.
The estimated schedule for completion of the project spans 48 months. It is anticipated that the site work will begin in the summer of 2020.
Michele Fisher, Public Relations Manager